홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-Acetylpiperidine-4-carbonyl chloride → 1-acetyl-N-[5-(3-furyl)[1,2,4]triazolo[1,5-a]pyridin-2-yl]piperidine-4-carboxamide

HRID 2382821
인쇄

반응식

HRID 2382821 반응식
[O:1]1[CH:5]=[CH:4][C:3]([C:6]2[N:11]3[N:12]=[C:13]([NH2:15])[N:14]=[C:10]3[CH:9]=[CH:8][CH:7]=2)=[CH:2]1.[C:16]([N:19]1[CH2:24][CH2:23][CH:22]([C:25](Cl)=[O:26])[CH2:21][CH2:20]1)(=[O:18])[CH3:17]>>[C:16]([N:19]1[CH2:20][CH2:21][CH:22]([C:25]([NH:15][C:13]2[N:14]=[C:10]3[CH:9]=[CH:8][CH:7]=[C:6]([C:3]4[CH:4]=[CH:5][O:1][CH:2]=4)[N:11]3[N:12]=2)=[O:26])[CH2:23][CH2:24]1)(=[O:18])[CH3:17]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 1009501-Acetylpiperidine-4-carbonyl chlorideHCID 252159385-(Furan-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine

생성물 1

HCID 252135111-acetyl-N-[5-(3-furyl)[1,2,4]triazolo[1,5-a]pyridin-2-yl]piperidine-4-carboxamide

실험 절차

The title compound was prepared following procedure and work up described for example 19, but starting from 5-(3-furyl)[1,2,4]triazolo[1,5-a]pyridin-2-amine ((A2), 50 mg; 0.25 mmol; 1.0 eq.) and 1-acetylpiperidine-4-carbonyl chloride (57 mg; 0.3 mmol; 1.2 eq.) as a white powder (41.3 mg, 46%). HPLC, Rt: 2.15 min. (purity 93.3%). LC/MS, M+(ESI): 354.4, M−(ESI): 352.4.

출처 및 근거

ORD 기록
ord-ea5adeb5962c4fdca0a695a42008b278
출처 데이터셋
uspto-grants-2012_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08263595B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트